The December 2026 Depo-Provera Trial: What the First Bellwether Verdict Means for 3,769 Cases

Q: What is a bellwether trial and why does it matter?

A bellwether trial is a representative test case — or small group of cases — selected from an MDL to go to actual jury trial. The verdict reveals how juries respond to the evidence, which is the single most powerful driver of global settlement negotiations. A large plaintiff verdict creates massive financial pressure on the defendant to settle the remaining thousands of cases rather than risk similar verdicts at trial.

Q: If the plaintiff wins the bellwether, will I get paid automatically?

Not automatically, but a plaintiff verdict triggers an intense push toward global settlement. Pfizer would face the prospect of thousands more jury trials, each potentially producing a large verdict. This pressure has historically driven pharmaceutical defendants to negotiate billions in global settlements. Roundup settled for $10.9 billion and 3M earplug MDL for $6 billion — both after plaintiff bellwether verdicts.

Q: What if the defense wins the bellwether trial?

A defense verdict does not end the litigation. The MDL judge typically runs multiple bellwether trials over time. Plaintiffs' attorneys may appeal, select different representative cases, or argue that the losing case was not truly representative. Historically, MDLs with mixed bellwether results still produce substantial global settlements as both sides recognize the ongoing risk of continued litigation.

The Short Answer

On December 7, 2026, the first representative Depo-Provera case goes before a jury. This bellwether verdict will set the benchmark that drives settlement values for all 3,769+ pending meningioma cases. Filing before the trial is complete is strongly advisable — once a verdict is in, the settlement process accelerates rapidly and late filers are often at a disadvantage.

Patricia W. filed her Depo-Provera lawsuit in the spring of 2024, a year after her meningioma diagnosis. Her attorney told her something at the time that stayed with her: "You won't be going to court. But a trial is coming — and that trial will determine what your case is worth."

Patricia didn't fully understand what that meant until her attorney explained the bellwether process. Her individual case — seventeen years of Depo-Provera use, a Grade II meningioma requiring surgery, and permanent partial vision loss — would never go to trial. But a carefully selected test case would. And the jury's verdict on that case would anchor the value of hers.

"I stopped thinking of December 2026 as someone else's problem," Patricia said. "That trial is my trial."

What Is a Bellwether Trial?

In mass tort MDLs, individual trials for all 3,769 plaintiffs would be logistically impossible — they would take decades and cost billions. Instead, the MDL judge selects a small number of representative cases — "bellwethers" — to go to actual jury trial. These cases are chosen to reflect the range of typical plaintiff experience.

search

Test the Evidence

Reveals how real jurors respond to the scientific evidence linking Depo-Provera to meningioma — what works and what doesn't.

attach_money

Set Case Values

The verdict amount anchors the compensation matrix applied to all cases — each plaintiff's individual settlement is calibrated against the bellwether baseline.

handshake

Drive Settlements

A plaintiff verdict creates enormous pressure on the defendant to settle — facing thousands more potential jury awards — rather than continue to litigate.

The 2026 Litigation Timeline

Now

Discovery and Case Preparation

Plaintiffs' attorneys depose Pfizer executives, gather internal company documents, and prepare expert witness reports. New plaintiffs continue to file and join the MDL. This phase determines the quality of evidence presented at trial.

Jun '26

Daubert Hearing — The Gateway to Trial

The federal judge determines whether expert scientific testimony linking Depo-Provera to meningioma meets the Daubert standard for reliability and relevance. Plaintiffs' experts will present epidemiological and pharmacological evidence including the BMJ study showing 5.55x meningioma risk. A favorable ruling — widely expected given the published science — allows expert testimony to proceed to the jury.

Dec '26

First Bellwether Trial — December 7, 2026

The first representative Depo-Provera case goes to jury. The plaintiff — a woman who used Depo-Provera for multiple years and was diagnosed with a meningioma — will present her case against Pfizer. The jury's verdict sets the tone for all settlement negotiations.

2027

Global Settlement Negotiations Accelerate

Following the bellwether verdict, both sides have a realistic picture of case values. If the verdict favors plaintiffs, Pfizer faces catastrophic exposure across 3,769+ cases. Settlement negotiations are expected to begin or intensify, with a global settlement fund likely announced within 12–24 months of the verdict.

2028

Settlements Distributed to Plaintiffs

Individual settlement amounts are calculated based on each plaintiff's specific case profile. Disbursements are made after MDL administration deducts litigation expenses and attorney fees. Early filers in strong settlement tiers begin receiving compensation.

What Each Verdict Outcome Means for Your Case

If Plaintiff Wins the Bellwether

✓Verdict amount becomes the value anchor for all cases
✓Pfizer faces massive exposure across 3,769+ cases
✓Settlement negotiations become urgent for Pfizer
✓Global settlement fund creation likely within 12–18 months
✓Historical parallel: Roundup $10.9B, Talcum Powder $6.9B, 3M Earplug $6B

If Defense Wins the Bellwether

→Pfizer may offer lower initial settlement amounts
→Plaintiffs' attorneys may appeal the decision
→Additional bellwether cases likely selected for new trials
→MDL continues — litigation does not end on one verdict
→Many MDLs recover from early defense wins and still settle

Historical Precedents: What Bellwether Verdicts Have Done

Roundup MDL

First plaintiff verdict in 2018: $289M. Final global settlement 2020: $10.9 billion for 125,000 cases.

Johnson & Johnson Talc

Bellwether verdict $72M in 2016. Multiple state court verdicts followed. Global settlements totaling $6.9B+.

3M Combat Arms Earplugs

85 bellwether trials. After mixed results, 3M agreed to $6 billion global settlement in 2023.

Why Filing Before the Trial Matters

The period before a bellwether verdict is typically the most favorable time to file. Here is why timing matters in MDL litigation:

Benefits of Filing Now

✓More time to gather and organize evidence
✓Included in early settlement tiers that MDL administrators typically prioritize
✓Better positioned in discovery process
✓Statute of limitations protected immediately upon filing

Risks of Waiting

✗Filing volumes surge after large plaintiff verdicts
✗Late filers may be placed in later settlement tiers
✗Statute of limitations may expire while waiting
✗Records become harder to obtain as time passes

Frequently Asked Questions

When is the first Depo-Provera trial?add

The first Depo-Provera bellwether trial is scheduled to begin December 7, 2026, in the Northern District of Illinois as part of MDL No. 3:23-md-03012. A Daubert hearing in June 2026 will first determine whether expert scientific testimony is admissible — a critical step before trial proceeds.

What is a bellwether trial and why does it matter?add

A bellwether trial is a representative test case selected from the MDL to go before an actual jury. The verdict reveals how juries respond to the evidence, which is the single most powerful driver of global settlement negotiations. A large plaintiff verdict creates massive financial pressure on Pfizer to settle the remaining thousands of cases.

If the plaintiff wins the bellwether, will I get paid automatically?add

Not automatically, but a plaintiff verdict triggers intense movement toward global settlement. Pfizer would face thousands more potential jury verdicts. This pressure historically drives pharmaceutical defendants to negotiate billions in global settlements — as seen in Roundup ($10.9B), J&J Talc ($6.9B+), and 3M Earplug ($6B) MDLs.

What if the defense wins the bellwether trial?add

A defense verdict does not end the litigation. MDL judges typically run multiple bellwether trials. Plaintiffs' attorneys may appeal, select different representative cases, or adjust strategy. Historically, MDLs with mixed bellwether results still produce substantial global settlements — both sides recognize the ongoing risk of continued litigation.

What is the Daubert hearing in June 2026?add

A Daubert hearing is a pretrial proceeding where the judge evaluates whether expert scientific testimony meets federal standards for reliability. The Daubert hearing in the Depo-Provera MDL will determine whether expert witnesses can testify to the jury about the scientific link between medroxyprogesterone acetate and meningioma. A favorable ruling — expected given the strength of the BMJ and French cohort study evidence — is required for the trial to proceed meaningfully.

Does filing before the bellwether trial help my case?add

Filing earlier is generally advantageous. Early filers have more time to gather evidence, are better positioned in discovery, and are included in initial settlement tiers that MDL administrators typically prioritize. After a large bellwether verdict, filing volumes surge and settlement processes become more complex. Filing now preserves your position at no cost.

How much could a Depo-Provera settlement be worth?add

Settlement values in pharmaceutical MDLs vary widely based on individual case factors. Comparable MDLs involving serious neurological injuries have produced individual settlements ranging from tens of thousands to several million dollars depending on surgery required, residual deficits, lost income, and duration of drug use. Specific Depo-Provera settlement ranges will be anchored by the December 2026 bellwether verdict.

The December Trial Is 7 Months Away. Don't Wait.

Filing before the bellwether verdict puts you in the strongest position. The litigation window before trial is when early filers gain their advantages — more time, better case preparation, and priority placement in settlement tiers. If you used Depo-Provera for a year or more and were diagnosed with a meningioma, start your free case review today.

Get Your Free Case Review — File Before Trial

$0 upfront · Contingency fee only · No obligation